These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 428235)

  • 1. Plasma levels of norethindrone and effect upon ovarian function during treatment with silastic implants containing norethindrone.
    Odlind V; Weiner E; Johansson ED
    Contraception; 1979 Feb; 19(2):197-206. PubMed ID: 428235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subdermal norethindrone pellets -- a method for contraception?
    Odlind V; Moo-Young AJ; Gupta GN; Weiner E; Johansson ED
    Contraception; 1979 Jun; 19(6):639-48. PubMed ID: 487813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of a contraceptive vaginal ring releasing norethindrone and estradiol: ovarian function, bleeding control and lipoprotein patterns.
    Victor A; Lithell H; Selinus I; Vessby B
    Ups J Med Sci; 1984; 89(2):179-88. PubMed ID: 6380076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone.
    Goebelsmann U; Stanczyk FZ; Brenner PF; Goebelsmann AE; Gentzschein EK; Mishell DR
    Contraception; 1979 Mar; 19(3):283-313. PubMed ID: 572279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contraceptive efficacy of bioabsorbable pellets of norethindrone (NET) as subcutaneous implants: phase II clinical study.
    Singh M; Saxena BB; Landesman R; Ledger WJ
    Adv Contracept; 1985 Jun; 1(2):131-49. PubMed ID: 3842214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contraceptive efficacy, pharmacokinetics, and safety of Annuelle biodegradable norethindrone pellet implants.
    Raymond EG; Singh M; Archer DF; Saxena BB; Baker J; Cole D
    Fertil Steril; 1996 Dec; 66(6):954-61. PubMed ID: 8941061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of norethindrone acetate released from a single silastic implant on serum FSH, LH, progesterone and estradiol-17beta of women during first eight months of treatment.
    Rahman SA; Jha P; Laumas V; Jain AK; Dileepkumar ; Takkar D; Hingorani V; Laumas KR
    Contraception; 1977 Nov; 16(5):487-97. PubMed ID: 590011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: Phase I. Clinical study.
    Gupta GN; Saxena BB; Landesman R; Ledger WJ
    Fertil Steril; 1984 May; 41(5):726-31. PubMed ID: 6714449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum norethindrone levels and menstrual pattern after the use of norethindrone implants in rhesus monkeys.
    Jha P; Murugesan K; Farooq A
    Contraception; 1995 Feb; 51(2):117-20. PubMed ID: 7750289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of norethindrone after i.m. injection of 200 mg norethindrone enanthate.
    Weiner E; Johansson ED
    Contraception; 1975 Apr; 11(4):419-25. PubMed ID: 1122756
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of norethisterone oenanthate on ovarian function.
    Weiner E; Johansson ED
    Acta Endocrinol (Copenh); 1976 Oct; 83(2):386-92. PubMed ID: 989667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norethisterone contraceptive microspheres.
    Rivera R; Alvarado G; Flores C; Aldaba S; Hernandez A
    J Steroid Biochem; 1987; 27(4-6):1003-7. PubMed ID: 3695501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of norethidrone in Indian women receiving norethidrone enanthate (20 mg) injectable.
    Prasad KV; Nair KM; Sivakumar B; Prema K; Rao BS
    Contraception; 1981 May; 23(5):497-506. PubMed ID: 7285573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, pharmacodynamic and endometrial effects of a single dose of 200 mg norethisterone enanthate.
    Zalányi S; Landgren BM; Johannisson E
    Contraception; 1984 Sep; 30(3):225-37. PubMed ID: 6509978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II clinical study of implanted norethindrone pellets for longterm contraception in women. Program for Applied Research on Fertility Regulation.
    Adv Contracept; 1985 Dec; 1(4):295-304. PubMed ID: 3842220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of ovulation after daily, oral administration of 10 mg of norethindrone on day 15-22 and on day 8-15 of the human menstrual cycle.
    Nygren KG; Johansson ED
    Contraception; 1974 Mar; 9(3):257-64. PubMed ID: 4442275
    [No Abstract]   [Full Text] [Related]  

  • 18. Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation.
    Voordouw BC; Euser R; Verdonk RE; Alberda BT; de Jong FH; Drogendijk AC; Fauser BC; Cohen M
    J Clin Endocrinol Metab; 1992 Jan; 74(1):108-17. PubMed ID: 1727807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins.
    McGuire JL; Bariso CD; Yuliano E; Hume RJ; Pasquale SA
    Contraception; 1975 Mar; 11(3):329-38. PubMed ID: 1116369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of three oral contraceptives: comparison of bleeding patterns by contraceptive types and steroid levels.
    Saleh WA; Burkman RT; Zacur HA; Kimball AW; Kwiterovich P; Bell WK
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1740-5; discussion 1745-7. PubMed ID: 8317516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.